Related Experiment Video
Updated: Feb 17, 2026
06:31
Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
3.2K
What can palindromic rheumatism tell us?
1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Best Practice & Research. Clinical Rheumatology
|December 10, 2017
Summary
Palindromic rheumatism (PR) involves recurrent joint inflammation and is linked to rheumatoid arthritis (RA). Understanding PR
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Palindromic rheumatism (PR) presents as recurrent, self-limiting inflammatory episodes affecting the joints.
- A strong association exists between PR and rheumatoid arthritis (RA), with many PR patients progressing to RA and exhibiting anti-citrullinated peptide (anti-CCP) antibodies.
- PR is frequently viewed as a potential precursor or prodromal stage of RA.
Purpose of the Study:
- To investigate the distinct clinical and imaging characteristics of PR compared to RA.
- To explore the underlying disease mechanisms that differentiate PR from RA.
- To inform the development of targeted therapeutic strategies for PR.
Main Methods:
- Clinical assessment of patients with palindromic rheumatism.
- Imaging studies to evaluate joint involvement and inflammation.
- Serological analysis for autoantibodies, including anti-CCP antibodies.
Main Results:
- Palindromic rheumatism exhibits unique clinical and imaging features that distinguish it from established rheumatoid arthritis.
- Despite overlapping serological markers like anti-CCP antibodies, the distinct phenotypes suggest different etiological pathways.
- The study highlights significant differences in presentation and progression between PR and RA.
Conclusions:
- Palindromic rheumatism and rheumatoid arthritis, while associated, possess distinct clinical and potentially mechanistic profiles.
- Further research into the specific disease mechanisms of PR is crucial for developing effective, targeted treatments.
- PR may represent a distinct entity or an early, unique manifestation within the spectrum of inflammatory arthropathies.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
577
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
577
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
696
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
696
01:11Genome-wide Association Studies-GWAS
15.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.8K
01:22Pericarditis I: Introduction
456
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
456
01:21Rheumatic Heart Disease III: Medical Management
393
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
393
01:20The JAK-STAT Signaling Pathway
13.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.1K